Nike announced limited edition “Back to the Future” shoes, Nike Mag, last week in an online post. The feature that makes the sneakers so special is “power laces” – an individually responsive system that senses the wearer’s motion to provide adaptive on-demand comfort and support.
Nike Inc. President and Chief Executive Officer Mark Parker said, “We started creating something for fiction and we turned it into fact, inventing a new technology that will benefit all athletes.”
The announcement did not reveal if or when the sneakers will be available to the public. It just said that the Nike Mag is a limited edition release and will only be available via auction, with all proceeds going to the Michael J. Fox Foundation for Parkinson's Research.
“By imagining the future, we create it. Product that comes alive, with on-demand comfort and support when you need, product that senses you and adapts to you is right around the corner,” added Parker.
It further added that the specific details on the auctions will be posted in spring 2016.


Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 



